Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!
Sana Biotechnology (SANA) Financial results for the third quarter of 2021.
GAAP net loss is -$0.46.
Cash, cash equivalents and market securities of the company are $866.11 million
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей
Загрузка...